Results 41 to 50 of about 11,913 (332)

Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma [PDF]

open access: yes, 2010
Background Formoterol is a long-acting beta(2)-agonist but because it has a fast onset of action it can also be used as a relief medication. Objectives To asses the efficacy and safety of formoterol as reliever therapy in comparison to short-acting ...
Cates, CJ, Welsh, EJ
core   +1 more source

Factors associated with appropriate inhaler use in patients with COPD - lessons from the REAL survey [PDF]

open access: yes, 2018
The authors thank Clarice Field (PhD) and Paul McKiernan (PhD) of Novartis for providing medical writing support, which was funded by Novartis AG, Basel, Switzerland, in accordance with Good Publication Practice (GPP3) guidelines (http://www.ismpp.org ...
Gasser, Matthias   +5 more
core   +1 more source

Evaluating Patient Preferences of Maintenance Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Discrete Choice Experiment in the UK, USA and Germany. [PDF]

open access: yes, 2020
Introduction: With increasing availability of different treatments for chronic obstructive pulmonary disease (COPD), we sought to understand patient preferences for COPD treatment in the UK, USA, and Germany using a discrete choice experiment (DCE ...
Doll, HA   +7 more
core   +1 more source

Most frequent errors in inhalation technique of patients with asthma treated at a tertiary care hospital

open access: yesEinstein (São Paulo)
Objective: To demonstrate the most frequent errors in inhalation technique in patients with asthma undergoing treatment at a tertiary care hospital. Methods: A cross-sectional study with a convenience sample of asthma patients aged 18 years or over ...
Carlos Leonardo Carvalho Pessôa   +7 more
doaj   +1 more source

How to match the optimal currently available inhaler device to an individual child with asthma or recurrent wheeze [PDF]

open access: yes, 2015
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in ...
Dekhuijzen, Richard   +6 more
core   +5 more sources

Characterization of a Human Powered Nebulizer Compressor for Resource Poor Settings [PDF]

open access: yes, 2014
Background Respiratory disease accounts for three of the ten leading causes of death worldwide. Many of these diseases can be treated and diagnosed using a nebulizer. Nebulizers can also be used to safely and efficiently deliver vaccines.
Hallberg, Christopher J.   +4 more
core   +2 more sources

Swirling flow and capillary diameter effect on the performance of an active dry powder inhalers

open access: yesMedicine in Novel Technology and Devices, 2023
For patients with lung disease, dry powder inhalers (DPI) are profoundly beneficial. The current study introduces and develops a series of dry powder inhalers (DPIs). A capsule-based (size 0) active DPI was considered.
Mohammad Hasan Taheri   +6 more
doaj   +1 more source

Cepharanthine Dry Powder Inhaler for the Treatment of Acute Lung Injury

open access: yesMolecules, 2023
Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) induces a severe cytokine storm that may cause acute lung injury/acute respiratory distress syndrome (ALI/ARDS) with high clinical morbidity and mortality in infected individuals. Cepharanthine
Di Liang   +8 more
doaj   +1 more source

Concept review of dry powder inhalers : correct interpretation of published data [PDF]

open access: yes, 2015
Peer reviewedPublisher ...
Chrystyn, Henry, Price, David
core   +1 more source

Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. [PDF]

open access: yes, 2014
BACKGROUND: Inhaled corticosteroids (ICS) are anti-inflammatory drugs that have proven benefits for people with worsening symptoms of chronic obstructive pulmonary disease (COPD) and repeated exacerbations.
Agarwal   +163 more
core   +1 more source

Home - About - Disclaimer - Privacy